C3ai Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C3ai inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C3ai Inc Today - Breaking & Trending Today

Stock Analysts' Price Target Changes for June 1st (AAP, ABNB, ADM, AI, AJX, AMBA, APPH, AVY, BG, BIIB)

Stock Analysts’ price target changes for Thursday, June 1st: Advance Auto Parts (NYSE:AAP) had its target price cut by Barclays PLC from $129.00 to $69.00. Advance Auto Parts (NYSE:AAP) had its target price trimmed by Citigroup Inc. from $126.00 to $76.00. Advance Auto Parts (NYSE:AAP) had its target price reduced by Morgan Stanley from $130.00 […] ....

United States , Robertw Baird , Stifel Nicolaus , Sanfordc Bernstein , Piper Sandler , Raymond James , Morgan Stanley , America Co , National Bank Financial , Real Estate Investment Trust , National Bank , Victoria Secret Co , Credo Technology Group , Descartes Systems Group , Wells Fargo Company , Royal Bank , Taiwan Semiconductor Manufacturing , Lauder Companies , Barclays Plc , Formula One Group , Lyondellbasell Industries , Truist Financial Co , Citigroup Inc , Cantor Fitzgerald , Canaccord Genuity Group Inc , Auto Parts Inc ,

Research Analysts' Upgrades for June 1st (AI, AYX, AZO, BLUE, BLX, BRLXF, CG, CHWY, CNVVY, CPHRF)

Research Analysts’ upgrades for Thursday, June 1st: C3.ai (NYSE:AI) was upgraded by analysts at Wedbush from a neutral rating to an outperform rating. The firm currently has $50.00 target price on the stock, up from their previous target price of $24.00. Alteryx (NYSE:AYX) was upgraded by analysts at Bank of America Co. from a neutral […] ....

United States , Wolters Kluwer , Stifel Nicolaus , Raymond James , Neste Oyj , Gordon Haskett , Nextera Energy Partners , Wolfe Research , Research Analyst , Royal Bank , America Co , Morgan Stanley , Goldman Sachs Group Inc , Cipher Pharmaceuticals , Jpmorgan Chase Co , Convatec Group , Inc Daily , Credit Suisse Group , Intercorp Financial Services , Barclays Plc , Resources Group , Suisse Group , Tec Group , Financial Services , Goldman Sachs Group , Era Energy Partners ,

Research Analysts' Recent Ratings Updates for C3.ai (AI)

Several brokerages have updated their recommendations and price targets on shares of C3.ai (NYSE: AI) in the last few weeks: 6/9/2022 – C3.ai was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “C3.ai Inc. is an enterprise AI software provider for accelerating digital transformation. C3.ai […] ....

United States , Juho Parkkinen , Piper Sandler , Morgan Stanley , Securities Exchange Commission , Zacks Investment Research , Investment Advisers , Deutsche Bank Aktiengesellschaft , Princeton Global Asset Management , Ancora Advisors , Needham Company , Jpmorgan Chase Co , Canaccord Genuity Group Inc , Redwood City , Canaccord Genuity Group , Get Rating , Exchange Commission , Global Asset Management , Canada Pension Plan Investment Board , Pension Plan Investment Board , C3ai Inc , Nyse Ai ,

Research Analysts' Updated EPS Estimates for June 9th (ADIL, AI, ALSMY, AMRX, AMSC, BPMC, CVAC, DBTX, DTIL, IMVT)

Research Analysts’ updated eps estimates for Thursday, June 9th: Adial Pharmaceuticals (NASDAQ:ADIL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. […] ....

United States , New Jersey , Adial Pharmaceuticals Inc , Amneal Pharmaceuticals , Zacks Investment Research , Alliance Global Partners , Impax Laboratories Inc , Zillow Group , Research Analyst , Marinus Pharmaceuticals , American Superconductor Corporation , Adial Pharmaceuticals , Redwood City , North America , Superconductor Corporation , C3ai Inc , Alstom Sa , Amneal Pharmaceuticals Inc , American Superconductor Co , Blueprint Medicines Co , Decibel Therapeutics Inc , Precision Biosciences Inc , Immunovant Inc ,